Word

BTG

Status

Registered

Status Code

700

Status Date

Tuesday, October 9, 2018

Serial Number

86960150

Registration Number

5577939

Registration Date

Tuesday, October 9, 2018

Mark Type

3000

Filing Date

Thursday, March 31, 2016

Published for Opposition

Tuesday, June 12, 2018

Trademark Owner History

PROTHERICS MEDICINES DEVELOPMENT LIMITED -
BTG International Limited - Original Registrant

Classifications

41 Education, namely, developing, arranging and conducting educational conferences, seminars, workshops and programs and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments, pulmonary and thoracic surgery and procedures, and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrhages, and hematoma, cryoablation and distribution of course materials in connection therewith; Educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions and training in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments, pulmonary and thoracic surgery and procedures, and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrhages, and hematoma, cryoablation and distribution of course materials in connection therewith; Education services, namely, conducting online and telephonic instruction and courses in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments, pulmonary and thoracic surgery and procedures, and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrhages, and hematoma, cryoablation and distribution of course materials in connection therewith; provision of educational content, namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments, and pulmonary and thoracic surgery and procedures, and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma, cryoablation and distribution of course materials in connection therewith; providing educational training in relation to pulmonary and thoracic surgery and procedures and distribution of course materials in connection therewith; educational services, namely, development of multimedia educational content for use with mobile devices and computers, namely, a series of health-related questions for response from the user that result in a report that provides health-related information in the form of recommended educational resources and treatment information in relation to pulmonary and thoracic surgery and procedures, and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrhages, and hematoma and cryoablation; providing computer, electronic and on-line databases in the field of education concerning healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care, medical diseases, disorders and related treatments, and pulmonary and thoracic surgery and procedures, and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrhages, and hematoma, and cryoablation; provision of educational training in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; provision of educational training in the fields of health and medicine by means of a hotline services; arranging, and conducting educational conferences and programs and providing courses of instruction in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; Providing on-line non-downloadable publications in the nature of teaching guides, instructional materials, brochures and pamphlets in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; conducting educational seminars in the fields healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care and distribution of course materials therewith; information and advice in the field of educational training provided online from a computer database or the internet, all relating to healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; Non-downloadable electronic publications in the nature of teaching guides, instructional materials, brochures in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine, medical diseases, disorders and related treatments, and pulmonary and thoracic surgery and procedures, and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma and cryoablation; providing educational electronic online databases featuring information about medical education in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; providing online, non-downloadable electronic publications in the nature of electronic questionnaires in the field of healthcare, medicine, medical treatment and patient care; providing online, non-downloadable electronic patient reported outcome questionnaires in the fields of healthcare, medicine, medical treatment and patient care, patient reported outcomes, electronic patient reported outcome questionnaires and electronic patient reported outcome questionnaires for use with a telecommunications device

9 Computer hardware for medical imaging apparatus; computer firmware for controlling medical devices; computer firmware for controlling and managing patient medical information; computer hardware; computer peripherals; computer software and computer programs for medical monitoring, medical testing and patient evaluating programs; computer programs for controlling and managing patient medical information; computer software for use in medical devices, namely, software for the operation of medical devices and for analyzing the results of testing completed through medical devices; computer software for use in ultrasound devices, namely, software for the operation of ultrasound devices and for analyzing ultrasound images; computer software for use in the medical and pharmaceutical fields for the diagnosis, treatment, and management of health conditions and illnesses; computer software for the diagnosis, assessment, treatment, management, and aftercare of conditions in the fields of sclerotherapy, phlebology, angiology, proctology and interventional oncology and emphysema; computer software for the diagnosis, assessment, treatment, management, and aftercare of tumors; computer software and computer programmes providing information to medical professionals and patients, namely, computer software for the diagnosis, assessment, treatment, management, and aftercare of varicose veins, arterio-venous malformations, oesophageal varices, and hydroceles; computer software for the diagnosis, assessment, treatment, management and aftercare of emphysema; computer software for controlling and managing patient medical information; computer programs for use in the field of health care for the collection, maintenance and management of data for patient records, clinical diagnosis and assessment, patient treatment, goals management, outcome analysis, scheduling, health care facilities management, materials management, resources utilization, billing and accounting, and the review of health care facilities, services and clinical records; computer software for use by health care providers to analyse the outcomes of medical procedures and information relating to patient care; computer software for use in database management; computer databasing software for clinical use, clinical governance and clinical audit for collecting and analysing information relating to patient demographics, procedures and outcomes; computer operating software and computer displays for use in relation to medical purposes; computer hardware, computer operating software and computer operating programs in the field of ultrasound technology; apparatus for generating and transmitting ultrasound; electric and electronic control systems for controlling medical apparatus and instruments; electric and electronic control systems for controlling apparatus for generating and transmitting ultrasound; data processing apparatus and computers for controlling medical apparatus and instruments; data processing apparatus and computers for controlling apparatus for generating and transmitting ultrasound; computer software for controlling medical apparatus and instruments; computer software for controlling apparatus for generating and transmitting ultrasound; stands for computer hardware; medical software for processing and displaying images on ultrasound medical imaging apparatus; medical imaging software that records, monitors and analyses data using an ultrasound imaging probe; medical workstation comprised of computer hardware and software for gathering and transmitting patient image data for use during surgical procedures; software for processing digital images of the anatomy for diagnosis and treatment; software for medical imaging; computer software for ultrasound imaging and scanning; Downloadable publications in the nature of electronic questionnaires in the field of healthcare, medicine, medical treatment and patient care; Downloadable publications in the nature of electronic patient reported outcome questionnaires in the fields of healthcare, medicine, medical treatment and patient care, patient reported outcomes, electronic patient reported outcome questionnaires and electronic patient reported outcome questionnaires for use with a telecommunications device; downloadable publications in electronic form, namely, journals, magazines, periodicals, articles and books in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, patient care, medical diseases, disorders and related treatments; downloadable electronic publications, namely, journals, magazines, periodicals, articles and books provided on-line from databases or the internet in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, patient care, medical diseases, disorders and related treatments; optical viewing and recording apparatus for viewing and recording sound, images or data; spectrophotometers; replacement parts and fittings for all the aforesaid goods

5 Pharmaceutical, medicinal and veterinary preparations and substances, namely, vaccines, antitoxic sera, pharmaceutical preparations for the treatment of cancer, pharmaceutical preparations and substances for the treatment of thrombosis, embolisms, inflammation, and autoimmune disease, pharmaceutical preparations for the treatment of envenomation by snakes, veterinary preparations for the treatment of envenomation by snakes, liquid medical sealants, and liquid adhesives for use in surgical and clinical procedure; sanitary preparations for medical purposes; vaccines; pharmaceutical and medicinal preparations and substances, namely, sera containing polyclonal antibodies and fragments thereof and polyclonal antibodies and fragments derived therefrom all for use in treating snake envenomation, overdose of toxic substances, and sepsis; diagnostic reagents and substances, all for in vivo medical use; antibodies, and therapeutic antibodies for use as anti-lymphocytic agents for medical use; pharmaceutical preparations in the form of foams or for use in producing foams, for sclerotherapy, phlebology, angiology or proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; chemical reagents for medical and veterinary purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemico-pharmaceutical preparations for the treatment of envenomation by snakes; chemical preparations for medical or pharmaceutical purposes for use in the prevention and treatment of cancer, circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusions, blood clots, vascular issues and conditions, intracranial hemorrhages, cerebral hemorrhages, hematomas, and as antidotes; pharmaceutical preparations for the treatment of cancer; pharmaceutical and veterinary preparations for the reduction or elimination of circulating cytokines; pharmaceutical and veterinary preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; pharmaceutical and veterinary preparations for treatment of envenomation by snakes; pharmaceutical and veterinary preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of multiple neurodegeneration and multiple sclerosis; pharmaceutical preparations for the treatment of Alzheimer's disease; pharmaceutical preparations for the treatment of methotrexate toxicity; pharmaceutical preparations for the treatment of immune disorders namely, type 1 diabetes, psoriasis, coeliac disease and rheumatoid arthritis; pharmaceutical preparations for the treatment of cancer including prostate, oesophageal and brain cancer and leukaemias; pharmaceutical preparations for the treatment of sepsis; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolization; pharmaceutical preparations and substances for embolization of tumours and arteriovenous malformations (AVMs); pharmaceutical prepraations and substances for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical or veterinary purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemical preparations for medical or pharmaceutical purposes for the treatment of envenomation by snakes; medicines for the treatment of envenomation by snakes; pharmaceutical and veterinary preparations for the treatment of pre-eclampsia; chemical reagents for medical or veterinary therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity, and for use in the treatment of pre-eclampsia; chemical preparations for medical or pharmaceutical purposes and medicines for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity and for use in the treatment of pre-eclampsia; transarterial chemoembolization pharmaceutical preparations, vaccines and sera; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; radiotherapy substances for medical purposes, namely, radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiopharmaceuticals, namely, radiopharmaceuticals for the treatment of cancer and radiopharmaceutical preparations for use in nuclear medicine; therapeutic agents for delivery of radioactive material to target sites within the body; beads, including microscopic radioactive beads, for treatment of cancerous tumours; beads, including microscopic glass beads, impregnated with radioactive material for treatment of cancerous tumours; beads, including microscopic glass beads, impregnated with radioactive pharmaceutical preparations and consisting of radioactive material for treatment of cancerous tumours; radioactive glass beads impregnated with pharmaceutical preparations for the treatment of cancer; irradiated and radioactive microspheres used for in vivo therapeutic medical purposes, namely, beads in the nature of microscopic glass beads impregnated with radioactive pharmaceutical preparations for treatment of cancerous tumors; pharmaceutical preparations for use with ultrasound waves to enhance drug delivery and/or medically activate drugs; pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams or for use in producing foams for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; pharmaceutical preparations containing methotrexate antidotes; pharmaceutical preparations containing 5-fluorouracil antidotes; pharmaceutical preparations for use in chemotherapy and treatment of autoimmune diseases; pharmaceutical preparations used for regulating toxicity levels of therapeutic agents; pharmaceutical preparations used for depleting concentrations of therapeutic agents

10 Surgical, medical, dental and veterinary apparatus and instruments, namely, cryoablation needles, medical syringes, electrically powered tissue ablation devices, surgical and medical apparatus and instruments for administering pharmaceutical foams, surgical and medical apparatus and instruments for treatment of varicose veins, arterio-venous malformations, oesophageal varices and hydroceles, devices for intravenous administration of pharmaceutical foam, and diagnostic devices for grading the severity of venous conditions, snake envenomation and toxic drugs overdose, surgical and medical apparatus and instruments for use in minimally invasive cryoablation procedures; artificial limbs; orthopaedic articles, namely, implants made of artificial materials; medical syringes, medical cannula needles, medical tubing; surgical and medical apparatus for administering foams for use in sclerotherapy, phlebology, angiology or proctology, sterilisation treatment or for treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; surgical and medical devices for assessing the physical characteristics of such foams, namely, devices for intravenous administration of foam, medical diagnostic apparatus for analyzing the efficacy of sclerotherapy foams for medical purposes, and devices for monitoring the position and effect of foam in the human body; medical diagnostic devices for diagnosing all the above medical conditions, namely, varicose veins, arterio-venous malformations, oesophageal varices, spider veins hydroceles, cancer, tumors, and circulatory system conditions and pulmonary and thoracic conditions; haemofiltration devices for medical use; drug delivery embolisation apparatus, instruments and systems; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolisation; drug delivery embolisation systems; drug delivery apparatus and instruments comprised of injection syringes, and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical apparatus and instruments for embolisation; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body; Implantable radioactive therapy beads, namely, microscopic glass beads containing radioactive material and administered surgically for treatment of cancerous tumours; implantable radioactive therapy beads, namely, radioactive glass beads administered for treatment of cancerous tumours; surgical and medical apparatus and instruments for use in the circulatory system; medical devices which use ultrasound to enhance drug delivery and/or medically activate drugs; catheters for delivery of drugs or fluids sold together as a unit with controllers and power units for infusion catheters; ultrasonic drug delivery and drug activation apparatus sold together as a unit with controllers and power units therefor; needles for medical use, namely, cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for administering sclerosing foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; syringes for administering foams for use in sclerotherapy, phlebology, angiology or proctology; surgical and medical apparatus for administering foams for use in sterilisation treatment; surgical and medical apparatus for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hycroceles; syringes for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; medical devices for intravenous administration of sclerosing foam for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical devices for monitoring the position and effect of foam in the human body; medical diagnostic apparatus for diagnosing all the above medical conditions, namely, varicose veins, arterio-venous malformations, oesophageal varices, spider veins hydroceles, cancer, tumors, and circulatory system conditions and pulmonary and thoracic conditions; compression bandages; medical devices for use in pulmonary and thoracic surgery and procedures; lung volume reduction devices; artificial surgical implants for use in interventional pulmonology; surgical implants comprising artificial surgical implants for restoring, maintaining and improving patient breathing, and artificial surgical implants for restoring, maintaining and improving lung function; medical equipment for diagnostic purposes, namely, ultrasound imaging systems comprising ultrasound scanners and ultrasound imaging devices; electrically operated diagnostic testing apparatus and instruments for medical use, namely, electrically operated diagnostic testing apparatus and instruments for use in testing for symptoms, the presence of diseases or disorders or specific side effects in the fields of sclerotheraphy, phlebology, angiology proctology, interventional oncology, tumors, basal cell carcinoma, emphysema, varicose veins, arterio-venous malformations, oesophageal varices, hydroceles and skin complaints including psoriasis and eczema; ultrasonic medical diagnostic apparatus; replacement parts and fittings for all of the aforesaid goods

42 Providing on-line, non-downloadable educational software featuring instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments

The mark consists of a shaded circle with four diagonal narrowing notches inside of it; below the circle are the letters "BTG" in stylized lettering.
Color is not claimed as a feature of the mark.

Trademark Events

Oct 9, 2023

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Jul 13, 2023

Teas Change Of Correspondence Received

Jul 13, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Jul 13, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Mar 16, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Mar 16, 2023

Teas Change Of Correspondence Received

Mar 16, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Mar 16, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Mar 16, 2023

Teas Change Of Owner Address Received

Apr 12, 2022

Applicant/Correspondence Changes (Non-Responsive) Entered

Apr 12, 2022

Teas Change Of Correspondence Received

Apr 12, 2022

Teas Change Of Domestic Representatives Address

Apr 12, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Apr 12, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Apr 12, 2022

Teas Change Of Owner Address Received

Aug 30, 2021

Applicant/Correspondence Changes (Non-Responsive) Entered

Aug 30, 2021

Teas Change Of Correspondence Received

Aug 30, 2021

Attorney/Dom.Rep.Revoked And/Or Appointed

Aug 30, 2021

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Aug 30, 2021

Teas Change Of Owner Address Received

Apr 14, 2021

Automatic Update Of Assignment Of Ownership

Aug 29, 2020

Applicant/Correspondence Changes (Non-Responsive) Entered

Aug 29, 2020

Teas Change Of Correspondence Received

Aug 29, 2020

Teas Withdrawal As Domestic Representative Received

Aug 29, 2020

Attorney/Dom.Rep.Revoked And/Or Appointed

Aug 29, 2020

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Aug 29, 2020

Teas Change Of Owner Address Received

Oct 9, 2018

Registered-Principal Register

Jun 18, 2018

Changes/Corrections After Pub Approval Entered

Jun 18, 2018

Withdrawn From Issue - Petitions Office Request

Jun 18, 2018

Assigned To Petition Staff

Jun 12, 2018

Official Gazette Publication Confirmation E-Mailed

Jun 12, 2018

Published For Opposition

May 24, 2018

Teas Post Publication Amendment Received

May 23, 2018

Notification Of Notice Of Publication E-Mailed

May 9, 2018

Approved For Pub - Principal Register

May 9, 2018

Examiner's Amendment Entered

May 9, 2018

Notification Of Examiners Amendment E-Mailed

May 9, 2018

Examiners Amendment E-Mailed

May 9, 2018

Examiners Amendment -Written

Mar 14, 2018

Teas/Email Correspondence Entered

Mar 13, 2018

Correspondence Received In Law Office

Mar 13, 2018

Teas Response To Office Action Received

Sep 13, 2017

Notification Of Non-Final Action E-Mailed

Sep 13, 2017

Non-Final Action E-Mailed

Sep 13, 2017

Non-Final Action Written

Sep 6, 2017

Previous Allowance Count Withdrawn

Aug 15, 2017

Withdrawn From Pub - Og Review Query

Jul 31, 2017

Approved For Pub - Principal Register

Jul 18, 2017

Teas/Email Correspondence Entered

Jul 17, 2017

Correspondence Received In Law Office

Jul 17, 2017

Teas Request For Reconsideration Received

Feb 1, 2017

Notification Of Final Refusal Emailed

Feb 1, 2017

Final Refusal E-Mailed

Feb 1, 2017

Final Refusal Written

Jan 25, 2017

Teas/Email Correspondence Entered

Jan 25, 2017

Correspondence Received In Law Office

Jan 23, 2017

Teas Response To Office Action Received

Jul 23, 2016

Notification Of Non-Final Action E-Mailed

Jul 23, 2016

Non-Final Action E-Mailed

Jul 23, 2016

Non-Final Action Written

Jul 14, 2016

Assigned To Examiner

Apr 26, 2016

Preliminary/Voluntary Amendment - Entered

Apr 25, 2016

Assigned To Lie

Apr 7, 2016

Teas Voluntary Amendment Received

Apr 6, 2016

Notice Of Design Search Code E-Mailed

Apr 5, 2016

New Application Office Supplied Data Entered

Apr 4, 2016

New Application Entered